<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect
2
Cardiomyopathy in neurological disorders
3
CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.
4
Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis
5
Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy
6
Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports
7
Cardiomyopathy, nephropathy, and death in a 44-year-old man
8
Cardiomyopathy: a role for nitric oxide?
9
Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)
10
Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator
11
Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression
12
Cardiomyoplasty: Is it time to wrap it up?
13
Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ
14
Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease
15
Cardio-Oncology in Iran: Cardio-toxicity Registry
16
Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus
17
Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding
18
Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy
19
Cardioplegia in pediatric cardiac surgery: do we believe in magic?
20
Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts
21
Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum  
22
Cardioplegia-induced cell swelling: prevention by normothermic infusion
23
Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial
24
Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?
25
Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells
26
Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics
27
Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy
28
Cardioprotection and garlic
29
Cardioprotection and garlic
30
Cardioprotection and garlic
31
Cardioprotection and garlic
32
Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury
33
Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism
34
Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers
35
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger
36
Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage
37
Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin
38
Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase
39
Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion
40
Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action
41
Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least
42
Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist
43
Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery
44
Cardioprotection for Duchenne’s muscular dystrophy, ,
45
Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN
46
Cardioprotection in aged myocardium: Sites of failure in protective signalling
47
Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult
48
Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor
49
Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects
50
Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy
51
Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes
52
Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart
53
Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease
54
Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article
55
Cardio-protective and anti-cancer therapeutic potential of Nigella sativa
56
Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem
57
Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)
58
Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals
59
Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets
60
Cardioprotective and neuroprotective roles of oleuropein in olive
61
Cardioprotective and neuroprotective roles of oleuropein in olive
62
Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients
63
Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart
64
Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats
65
Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase
66
Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification
67
Cardioprotective effect of chronic hypoxia is blunted by hypercapnia
68
Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning
69
Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting
70
Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart
71
Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats
72
Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial
73
Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration
74
Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion
75
Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways
76
Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats
77
Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats
78
Cardioprotective effect of growth hormone secretagogues in rat heart
79
Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)
80
Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats
81
Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats
82
Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion
83
Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion
84
Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels
85
Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study
86
Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats
87
Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats
88
Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system
89
Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat
90
CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY
91
Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI
92
Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts
93
Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis
94
Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?
95
Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention
96
Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats
97
Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats
98
Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
99
Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study
100
Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat
101
Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats
102
Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours
103
Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure
104
Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia
105
Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article
106
Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury
107
Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism
108
Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins
109
cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure
110
Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart
111
cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice
112
Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury
113
Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart
114
Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia
115
Cardioprotective effects of preinfarction angina in elderly: same patients, different results?
116
Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats
117
Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
118
Cardioprotective effects of the NHE1-inhibitor EMD 87580
119
Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia
120
Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research
121
Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts  
122
Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article
123
Cardioprotective Potential of Antihypertensives
124
Cardioprotective potential of biobased gold nanoparticles
125
Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia
126
Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits
127
Cardio-protective properties of Momordica charantia in Albino Rats
128
Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats
129
Cardioprotective role of FGF2 in a murine model of low-flow ischemia  
130
Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model
131
Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals
132
Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery
133
Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran
134
CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL
135
CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA
136
Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting
137
Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery
138
Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation
139
Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics
140
Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans
141
Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility
142
Cardiopulmonary bypass during pregnancy
143
Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma
144
Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels
145
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant
146
Cardiopulmonary bypass in humans: bypassing unfractionated heparin
147
Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation
148
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis
149
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172
150
Cardiopulmonary bypass in pregnancy
151
Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases
152
Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function
153
Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension
154
Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans
155
Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow
156
Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia
157
Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia
158
Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation
159
Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions
160
Cardiopulmonary bypass, rewarming, and central nervous system dysfunction
161
Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit
162
Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital
163
Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys
164
Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves
165
Cardiopulmonary effects of HI-6 treatment in soman intoxication
166
Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys
167
Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome
168
Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure
169
Cardiopulmonary exercise test evidence of isolated right coronary artery disease
170
Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates
171
Cardiopulmonary exercise test in patients with subacute pulmonary emboli
172
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
173
Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
174
Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation
175
Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article
176
Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation
177
Cardiopulmonary exercise testing in patients with heart failure
178
Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article
179
Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure
180
Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma
181
Cardiopulmonary function in adult patients late after Fontan repair
182
Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities
183
Cardiopulmonary hazards of perihepatic packing for major liver injuries,
184
Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain
185
Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application
186
Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution
187
Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution
188
Cardiopulmonary mortality and air pollution
189
Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide
190
Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review
191
Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome
192
Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure
193
Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis
194
Cardiopulmonary responses to robotic end-effector-based walking and stair climbing
195
Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects
196
CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA
197
Cardiopulmonary resuscitation and neurological complications in the elderly
198
Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study
199
Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance
200
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study
201
Cardiopulmonary resuscitation in nursing homes
202
CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY
203
Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study
204
Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study
205
Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey
206
Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,
207
Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance
208
cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)
209
Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article
210
Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis
211
Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists
212
Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?
213
Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.
214
Cardiopulmonary resuscitation: Historical perspective to recent investigations
215
Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India
216
Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study
217
Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study
218
Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats
219
Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure
220
Cardiorenal Effects of Recombinant Human Natriuretic Peptides
221
Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article
222
Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure
223
Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.
224
Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats
225
Cardiorenal Syndrome
226
Cardiorenal syndrome
227
Cardiorenal Syndrome Review Article
228
Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia
229
Cardiorenal Syndrome or Renocardiac Syndrome
230
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure
231
Cardio-renal-anemia syndrome: a report of three cases
232
Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study
233
Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs
234
Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses
235
Cardiorespiratory challenges in Rettʹs syndrome
236
Cardiorespiratory changes during upper gastrointestinal endoscopy
237
Cardio-respiratory control during early development in the model animal zebrafish
238
Cardio-respiratory coupling in untreated patients with major depression
239
CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA
240
Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study
241
Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?
242
Cardiorespiratory fitness and coronary heart disease risk factor association in women
243
Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy
244
Cardiorespiratory Fitness and Metabolic Risk
245
Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review
246
Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension
247
Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study
248
Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention
249
Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template
250
Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents
251
Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study
252
Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)
253
Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men
254
Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial
255
Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus
256
Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure
257
Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance
258
Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension
259
Cardiorespiratory responses to exercise after repair of the univentricular heart
260
Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study
261
Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state
262
Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training
263
Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury
264
Cardioscopic guidance of linear lesion creation for radiofrequency ablation
265
Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis
266
CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects
267
CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy
268
Cardiosource is a good source for definition of trial acronyms
269
Cardiospermum halicacabum Linn.: Food and Drug
270
Cardiothoracic Surgeons Divided By a Common Language
271
Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox
272
Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement
273
Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3
274
Cardiothoracic surgery: a specialty in transition—good to great?
275
Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation
276
Cardiotocography and medicolegal issues
277
Cardiotocography in the Prognosis of Perinatal Outcome
278
Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article
279
Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial
280
Cardiotocography Waveform Analysis Using Image Extraction Technique
281
Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass
282
Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots
283
Cardiotonic Drugs from the Avicenna's Point of View
284
Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine
285
Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats
286
Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats
287
Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy
288
Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique
289
Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique
290
Cardiotoxicity associated with sunitinib
291
Cardiotoxicity associated with sunitinib
292
Cardiotoxicity associated with sunitinib – Authorsʹ reply
293
Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer
294
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
295
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
296
Cardiotoxicity of 5-flourouracil: two case reports
297
Cardiotoxicity of cytotoxic drugs
298
Cardiotoxicity of Plants in Iran: a Review
299
Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)
300
Cardiotoxicity Research in Breast Cancer Patients: Past and Future
301
Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised
302
Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience
303
Cardiotrophin-1 in Patients with Acute Myocardial Infarction
304
Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli
305
Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts  
306
Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats
307
Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes
308
Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines
309
Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation
310
Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy
311
Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article
312
Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article
313
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms
314
Cardiovascular abnormalities in hyperthyroidism
315
Cardiovascular Abnormalities in Hyperthyroidism
316
Cardiovascular Abnormalities in Hyperthyroidism
317
Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study
318
Cardiovascular abnormalities in never-treated hypertensives according to nondipper status
319
Cardiovascular Abnormalities in Sickle Cell Disease
320
Cardiovascular activity and the antibody response to vaccination
321
Cardiovascular adaptations to endurance training and detraining in young and older athletes
322
Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly
323
Cardiovascular Aging: What We Can Learn From Caloric Restriction
324
Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)
325
Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats
326
Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade
327
Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
328
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
329
Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus
330
Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats
331
Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep
332
Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?
333
Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study
334
Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)
335
Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization
336
Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
337
Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency
338
Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats
339
Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial
340
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension
341
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture
342
Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study
343
Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran
344
Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers
345
Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer
346
Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes
347
Cardiovascular anomalies associated with chromosome 22q11.2 deletion
348
Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome
349
Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study
350
Cardiovascular applications for artifical structural proteins produced by recombinant technologies
351
Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS
352
Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
353
Cardiovascular autonomic function in healthy adolescents
354
Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease
355
Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria
356
Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats
357
Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age
358
Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: A cross-sectional survey
359
Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice
360
Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes
361
Cardiovascular benefits of nuts
362
Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011
363
Cardiovascular cavitation
364
Cardiovascular changes during induced emotion: An application of langʹs theory of emotional imagery
365
Cardiovascular changes in response to ovarian stimulation
366
Cardiovascular Characteristics in American Youth With Prehypertension
367
Cardiovascular characterization of Pkd2+/LacZ mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2)
368
Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient
369
Cardiovascular Complications in Infants of Diabetic Mothers: An Observational Study in a Pediatric Cardiology Clinic in Tehran
370
Cardiovascular Complications in Obstructive Sleep Apnea Syndrome
371
Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dَria operation
372
Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management
373
Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article
374
Cardiovascular Complications of COVID-19 in Patients With Multiple Sclerosis: A Lesson From Our Experience
375
Cardiovascular Complications of Direct Laryngoscopy vs Video Laryngoscopy in Patients over 65 Years Old
376
Cardiovascular complications of malignant carcinoid disease, ,
377
Cardiovascular Complications of Radiotherapy
378
Cardiovascular Complications of the Guillain-Barré Syndrome
379
Cardiovascular Conditions in Patients With Aluminum Phosphide Poisoning
380
Cardiovascular consequences of laparoscopic surgery
381
Cardiovascular consequences of sleep apnea: I -Epidemiology
382
Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms
383
Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment
384
Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review
385
Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture
386
Cardiovascular control in Antarctic fish
387
Cardiovascular data on sildenafil citrate: Introduction
388
Cardiovascular Death and Cancer Death—Competing Risk?
389
Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature
390
Cardiovascular determinants of plasma fibronectin in an elderly population: The EVA study
391
Cardiovascular disease
392
Cardiovascular Disease Among International Travellers
393
Cardiovascular disease among Mexican Americans
394
Cardiovascular disease and bone
395
Cardiovascular disease and chronic kidney disease: Insights and an update
396
Cardiovascular disease and cognitive performance in middle-aged and elderly men
397
Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia
398
Cardiovascular disease and neoplasms after pancreas transplantation
399
Cardiovascular disease and neoplasms after pancreas transplantation
400
Cardiovascular disease and neoplasms after pancreas transplantation
401
Cardiovascular Disease and Olympic Games in China
402
Cardiovascular disease and risk factors among 345 adults in rural India—the Andhra Pradesh Rural Health Initiative
403
Cardiovascular disease and risk factors in adults with hypopituitarism
404
Cardiovascular disease and risk factors in Montana American Indians and non-Indians Original Research Article
405
Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran
406
Cardiovascular Disease and Risk in Primary Care Settings in the United States
407
Cardiovascular disease and sexual functioning
408
Cardiovascular disease and sleep-related erections
409
Cardiovascular disease and the global tobacco epidemic: a wake-up call for cardiologists
410
Cardiovascular disease burden shifts
411
Cardiovascular disease detection using bio-sensing techniques
412
Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS)
413
Cardiovascular Disease in Adult and Pediatric HIV/AIDS
414
Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan
415
Cardiovascular Disease in Asian Americans: Unmasking Heterogeneity
416
Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval
417
Cardiovascular Disease in Chronic Renal Failure Patients
418
Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors
419
Cardiovascular disease in Hajj pilgrims
420
Cardiovascular disease in HIV infection
421
Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention
422
Cardiovascular disease in Latin America
423
Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?
424
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria Original Research Article
425
Cardiovascular disease in older people
426
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada: Cardiovascular Disease in COPD Patients
427
Cardiovascular disease in patients with chronic renal failure
428
Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country
429
Cardiovascular disease in persons with depressive and anxiety disorders
430
Cardiovascular disease in postmenopausal women: myths and reality
431
Cardiovascular disease in rheumatoid arthritis
432
Cardiovascular disease in South Asians
433
Cardiovascular disease in South Asians
434
Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection
435
Cardiovascular disease in the NHANES III
436
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
437
Cardiovascular disease in the tropics, ethics, and need for action
438
Cardiovascular Disease Knowledge among Cardiac Rehabilitation Patients in Eastern Iran: A Cross-Sectional Study
439
Cardiovascular disease knowledge among culturally Deaf patients in Chicago
440
Cardiovascular Disease Mortality and Years of Life Lost Attributable to Non-optimal Systolic Blood Pressure and Hypertension in Northeastern Iran
441
Cardiovascular Disease Mortality in Asian Americans
442
Cardiovascular Disease Mortality in Hispanics and Non-Hispanic Whites
443
Cardiovascular Disease Patient's Quality of Life in Tabriz City in Iran in 2018
444
Cardiovascular Disease Prevention among Youth: Visioning the Future
445
Cardiovascular Disease Prevention for Women Attending Breast and Cervical Cancer Screening Programs: The WISEWOMAN Projects
446
Cardiovascular Disease Prevention in Eastern Europe
447
Cardiovascular disease prevention in Russia: Challenges and opportunities
448
Cardiovascular Disease Prevention Research at the National Heart, Lung, and Blood Institute
449
Cardiovascular Disease Prevention Using Fixed Dose Pharmacotherapy in Iran: Updated Meta-Analyses and Mortality Estimation
450
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
451
Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria
452
Cardiovascular Disease Risk Factor Intervention in Low-Income Women: The North Carolina WISEWOMAN Project
453
Cardiovascular Disease Risk Factors
454
Cardiovascular Disease Risk Factors among Migrant Seasonal Agricultural Workers: Comparison with Local Residents
455
Cardiovascular Disease Risk Factors and Cardiac Markers among Male Cement Workers in Calabar, Nigeria
456
Cardiovascular Disease Risk Factors and Cognitive Impairment
457
Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women
458
Cardiovascular disease risk factors in 6–7-year-old Danish children: the Copenhagen School Child Intervention Study
459
Cardiovascular Disease risk Factors in Male Cigarette Smokers in Calabar, Southern Nigeria
460
Cardiovascular Disease Risk Factors in Patients with Confirmed Cardiovascular Disease
461
Cardiovascular Disease Risk Factors Profile in Individuals With Diabetes Compared With Non-Diabetic Subjects in North-East of Iran
462
Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population
463
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
464
Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
465
Cardiovascular disease risk profile among young Saudi women of Al-Qassim, Saudi Arabia: A cross-sectional study
466
Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System Original Research Article
467
Cardiovascular Disease Risk Stratification With Stress Single-Photon Emission Computed Tomography Technetium-99m Tetrofosmin Imaging in Patients With the Metabolic Syndrome and Diabetes Mellitus
468
Cardiovascular disease risks in adolescent males
469
Cardiovascular disease, chronopharmacotherapy, and the molecular clock
470
Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease Original Research Article
471
Cardiovascular disease—risk benefits of clean fuel technology and policy: A statistical analysis
472
Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly
473
Cardiovascular Diseases and Risk Factors in Finland
474
Cardiovascular Diseases before and after Renal Transplantation
475
Cardiovascular diseases do not influence the mental health outcome of older men with depression over 6 years
476
Cardiovascular diseases in Latin America and the Caribbean
477
Cardiovascular Diseases in Natural Disasters; a Systematic Review
478
Cardiovascular diseases in the mirror of science
479
Cardiovascular diseases, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals
480
Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review
481
Cardiovascular Disorders Risk Factors in Different Industries of Iran
482
Cardiovascular distribution of the calcium sensing receptor before and after burns
483
Cardiovascular Disturbances in Workers Exposed to Carbon Disulfide
484
Cardiovascular drug delivery with ultrasound and microbubbles
485
Cardiovascular Drug Interactions of Diclofenac and Dobutamine
486
Cardiovascular Dual Source Computed Tomography for Aortic Coarctation in a Neonate: One-Second Scan With Ultra-Low Radiation Dose
487
Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation
488
Cardiovascular dysautonomia in Parkinsonʹs disease with visual hallucinations
489
Cardiovascular Effect of Bans on Smoking in Public Places
490
Cardiovascular Effect of Bans on Smoking in Public Places: A Systematic Review and Meta-Analysis
491
Cardiovascular Effect of Cuneiform Nucleus During Hemorrhagic Hypotension
492
Cardiovascular Effect of Dorsal Periaqueductal Gray During Lipopolysaccharide-induced Hypotension
493
Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender related?
494
Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause
495
Cardiovascular Effects of a Trandolapril/Verapamil Combination in Patients With Mild to Moderate Essential Hypertension
496
Cardiovascular effects of a μ-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of action, ,
497
Cardiovascular Effects of Acute Organophosphate Poisoning
498
Cardiovascular effects of Adonis aestivalis in anesthetized sheep
499
Cardiovascular Effects of Aldosterone and Post–Acute Myocardial Infarction Pathophysiology
500
Cardiovascular Effects of Allium Sativum (Garlic): An Evidence-Based Review
501
Cardiovascular Effects of Androgenic Anabolic Steroids in Male Bodybuilders Determined by Tissue Doppler Imaging
502
Cardiovascular Effects of Antidepressants and Mood Stabilizers
503
Cardiovascular effects of breast cancer radiotherapy
504
Cardiovascular effects of caffeine in men and women
505
Cardiovascular Effects of Carbamazepine Toxicity, ,
506
Cardiovascular effects of carbon monoxide and cigarette smoking
507
Cardiovascular Effects of Carbon Monoxide Poisoning
508
Cardiovascular effects of centrally applied endothelin-11–31 and its relationship to endothelin-11–21 in rats
509
Cardiovascular Effects of Circular Training (Resistance-Interval) Combined with Berberine on Overweight Elderly Men
510
Cardiovascular effects of Danshen
511
Cardiovascular effects of estrogen
512
Cardiovascular Effects of Exercise: Role of Endothelial Shear Stress
513
Cardiovascular effects of fingolimod: A review article.
514
Cardiovascular effects of French horn playing
515
Cardiovascular Effects of Hyperhomocysteinemia in Conscious Unrestrained Rats
516
Cardiovascular effects of induced hypothermia after lung transplantation
517
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
518
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
519
Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy
520
Cardiovascular effects of milk enriched with ω-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia
521
Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in the Treatment of School-Aged Children with Attention-Deficit/Hyperactivity Disorder
522
Cardiovascular effects of nitrergic system of the pedunculopon-tine tegmental nucleus in anesthetized rats
523
Cardiovascular Effects of Olive, a Qur’anic Fruit: a Systematic Review
524
Cardiovascular effects of prolonged milrinone inhalation inpatients with pulmonary hypertension undergoing mitral valvereplacement
525
Cardiovascular effects of propranolol in normal and stressed female and male rats assessed by traditional and nonlinear dynamics methods
526
Cardiovascular effects of raloxifene: the arterial and venous systems
527
Cardiovascular Effects of Saffron: An Evidence-Based Review
528
Cardiovascular effects of sex hormones
529
Cardiovascular effects of sildenafil citrate and recommendations for its use
530
Cardiovascular effects of standardized hydroalcoholic extract of Ribes khorasanicum fruit in acute hypertensive rats
531
Cardiovascular effects of systemic cancer treatment
532
Cardiovascular effects of tadalafil
533
Cardiovascular effects of tadalafil in patients on common antihypertensive therapies
534
Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers
535
Cardiovascular effects of two amides (Piperine and Piperdardine) isolated from Piper tuberculatum Jacq.
536
Cardiovascular Emergencies in Cruise Ship Passengers
537
Cardiovascular endocrinology springs surprises
538
Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
539
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin: The JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvast
540
Cardiovascular event risk in relation to arterial stiffness in patients with subclinical peripheral atherosclerosis
541
Cardiovascular Event Risk: High-Density Lipoprotein and Paraoxonase
542
Cardiovascular Events and Football Tournaments
543
Cardiovascular Events and Mortality in Newly and Chronically Depressed Persons >70 Years of Age
544
Cardiovascular events and plasma atrial natriuretic peptide level in patients with hypertrophic cardiomyopathy
545
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
546
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
547
Cardiovascular events during initial antihypertensive therapy with either a calcium antagonist or a diuretic/beta-blocker: meta-analysis of 7 clinical trials
548
Cardiovascular Events in Patients With Coronary Plaque Rupture and Nonsignificant Stenosis
549
Cardiovascular Events in Patients With Fabry Disease: Natural History Data From the Fabry Registry
550
Cardiovascular Events in People With Type 2 Diabetes: Performance of Framingham, UKPDS, and ADVANCE Risk Equations
551
Cardiovascular Events in the 1996 Olympic Games
552
Cardiovascular Factors and Cognitive Impairment: A Role for Unsaturated Fatty Acids and Mediterranean Diet?
553
Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community: The Role of Atrial Remodeling/Dysfunction Original Research Article
554
Cardiovascular findings in patients with psoriasis.
555
Cardiovascular fitness and neurocognitive function in older Adults: a brief review
556
Cardiovascular Function and Predictors of Exercise Capacity in Patients With Colorectal Cancer
557
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice
558
Cardiovascular gene delivery: The good road is awaiting
559
Cardiovascular gene therapy Review Article
560
Cardiovascular Gene Therapy: Advances and Challenges
561
Cardiovascular Genetics, Genomics, and Proteomics
562
Cardiovascular genomics
563
Cardiovascular Genomics: Estimating the Total Number of Genes Expressed in the Human Cardiovascular System
564
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study
565
Cardiovascular Health among Adults in Syria: A Model from Developing Countries
566
Cardiovascular health and economic effects of smoke-free workplaces
567
Cardiovascular health and economic effects of smoke-free workplaces: Am J Med. 2004;117:32-38
568
Cardiovascular Health Awareness Program (CHAP): A community cluster-randomised trial among elderly Canadians
569
CARDIOVASCULAR HEALTH EDUCATION OF FAMILIES: THE IMPORTANCE OF SCHOOL-BASED PREVENTION STRATEGIES
570
Cardiovascular Health in Europe: A Global Problem
571
Cardiovascular Health in Men Attending for Abdominal Aortic Aneurysm Screening
572
Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective β1-Non-competitive antagonism Original Research Article
573
Cardiovascular imaging
574
Cardiovascular Imaging in Thalassemia: An Issue With Limited Data
575
Cardiovascular Imaging in the Management of Atrial Fibrillation Review Article
576
Cardiovascular implications of the factor V Leiden mutation
577
Cardiovascular Interventions in Clinical Practice
578
Cardiovascular Inventiveness Within the University of Minnesota Department of Surgery
579
cardiovascular involvement in blood cancers: all, aml, cll, and cml
580
Cardiovascular Involvement in Children with Osteogenesis Imperfecta
581
Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart
582
Cardiovascular involvement in systemic autoimmune diseases
583
Cardiovascular Issues in Hypogonadism and Testosterone Therapy
584
Cardiovascular Magnetic Resonance Determinants of Left Ventricular Noncompaction
585
Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy)
586
Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy
587
Cardiovascular magnetic resonance for the assessment of pulmonary arterial hypertension: toward a comprehensive CMR exam
588
Cardiovascular Magnetic Resonance for the Diagnosis of Acute Myocarditis: Prospects for Detecting Myocardial Inflammation
589
Cardiovascular magnetic resonance imaging demonstrates mitral valve endocarditis
590
Cardiovascular magnetic resonance imaging: Current and emerging applications Review Article
591
Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited: Comparison With Task Force Criteria and Genotype Original Research Article
592
Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Diagnostic Value of a Typical Pattern of Late Gadolinium Enhancement
593
Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Noninvasive Imaging Compared to Endomyocardial Biopsy Original Research Article
594
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
595
Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications
596
Cardiovascular Magnetic Resonance in Predicting the Reduction in Pulmonary Artery Pressure in Patients With Mitral Stenosis After Surgical or Interventional Treatment
597
Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: A review
598
Cardiovascular magnetic resonance of asymptomatic myocardial infarction
599
Cardiovascular magnetic resonance of iatrogenic ventricular scarring due to catheter ablation for left ventricular tachycardia
600
Cardiovascular Magnetic Resonance of imminent cardiac tamponade due to postpericardiotomy syndrome
601
Cardiovascular magnetic resonance ofacute myocardial infarction at a very early stage
602
Cardiovascular Magnetic Resonance Perfusion Imaging at 3-Tesla for the Detection of Coronary Artery Disease: A Comparison With 1.5-Tesla Original Research Article
603
Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy
604
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy Original Research Article
605
Cardiovascular Magnetic Resonance: Warren J. Manning and Dudley J. Pennell, London, UK, Churchill Livingstone 2002, 506 pages, 367 illustrations, US$120.00
606
Cardiovascular Malformations in Congenital Rubella Syndrome: A Case Report
607
Cardiovascular malformations in Fryns Syndrome
608
Cardiovascular Malformations in Infants of Diabetic Mothers: A Retrospective Case-Control Study
609
Cardiovascular Manifestation of a Family with Marfan’s Syndrome
610
Cardiovascular manifestations associated with influenza virus infection
611
Cardiovascular manifestations in COVID-19 patients: A systematic review and meta-analysis
612
Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients
613
Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes
614
Cardiovascular Manifestations of Carbon Monoxide Poisoning
615
Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study Original Research Article
616
Cardiovascular Manifestations of Moderate to Severe Carbon Monoxide Poisoning Original Research Article
617
Cardiovascular manifestations of pheochromocytoma
618
Cardiovascular Medications and Risk of Cancer
619
Cardiovascular medicine update
620
Cardiovascular monitoring advised during growth hormone therapy
621
Cardiovascular Morbidity and Mortality in Community-Dwelling Elderly Individuals With Calcification of the Fibrous Skeleton of the Base of the Heart and Aortosclerosis (The Cardiovascular Health Study)
622
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article
623
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
624
Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
625
Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure: A Multicenter, Randomized, Controlled Trial Original Research Article
626
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
627
Cardiovascular Morphing
628
Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)
629
Cardiovascular mortality focusing on socio-economic influence: The low-risk population of Halland compared to the population of Sweden as a whole
630
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
631
Cardiovascular Mortality in High-Risk Patients and T-786C Polymorphism in Promoter Region of the Endothelial Nitric Oxide Synthase Gene
632
Cardiovascular mortality in New York City after September 11, 2001
633
Cardiovascular mortality in patients followed up for diabetic foot
634
Cardiovascular Mortality of Turkish Nationals Residing in West Germany
635
Cardiovascular neurons of the rat brain express extracellular calcium-sensing receptors
636
Cardiovascular operations in patients with dialysis-dependent renal failure
637
Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase
638
Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort
639
Cardiovascular Outcome in Treated Hypertensive Patients with Responder, Masked, False Resistant, and True Resistant Hypertension
640
Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: A 10 year follow-up study
641
Cardiovascular Outcomes in Male Veterans With Rheumatoid Arthritis
642
Cardiovascular Outcomes in Randomized Trials: Should Time to First Event for “Hard” End Points Remain the Standard Approach?
643
Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses
644
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
645
Cardiovascular Pathology A platform for research, teaching, and clinical care
646
Cardiovascular pathology at the crossroads: the dilemma of cardiac pathologists
647
Cardiovascular pathology in the land of doges
648
Cardiovascular Pathology: a new journal for an old need
649
Cardiovascular pathology: Clinicopathological correlations and pathogenetic mechanisms : Schoen FJ, Gimbrone MA (editors) Williams and Wilkins, Georgia, USA; 229 pp.; £67.00; ISBN 0-683-07600-0
650
Cardiovascular Pathology: From whence we came … to where we are going
651
Cardiovascular pathology: maturation of a discipline and the Society for Cardiovascular Pathology
652
Cardiovascular patients’ experiences of living with pacemaker: Qualitative study
653
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations
654
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
655
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes: A RELAX Trial Ancillary Study
656
Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1
657
Cardiovascular Prevention in Asymptomatic Diabetic Patients
658
Cardiovascular Prevention in Diabetes Mellitus: No Magic Remedies
659
Cardiovascular prevention in the Hartslag Limburg project: Effects of a high-risk approach on behavioral risk factors in a general practice population
660
Cardiovascular professionalism and ethics in the modern era Review Article
661
Cardiovascular profile of loratadine
662
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: Results from the Angina Prognosis Study in Stockholm (APSIS) Original Research Article
663
Cardiovascular prognostic value of vascular involvement in Behcetʹs disease
664
Cardiovascular Property of Resistance Training With an Emphasis on PI3K/AKT1 Genes Expression in Type 2 Diabetic Rats
665
Cardiovascular protection and blood pressure reduction: a meta-analysis
666
Cardiovascular protection in haemophilia
667
Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters
668
Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo
669
Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence Review Article
670
Cardiovascular protective effect of darbepoetin-α: A long-acting erythropoietic analogue
671
Cardiovascular proteomic analysis
672
Cardiovascular Proteomics: Tools to Develop Novel Biomarkers and Potential Applications Review Article
673
Cardiovascular reactivity and hostility: The dynamic cerebral laterality effect
674
Cardiovascular reactivity, affective responses and performance related to the risk dimensions of coronary-prone behaviour
675
Cardiovascular recovery from laboratory stress: Biopsychosocial concomitants in older adults
676
Cardiovascular regulation by -atginine in the brain of rats : Role of the brain renin-angiotensin system and nitric oxide
677
CARDIOVASCULAR REGULATION IN TGR(mREN2)27 RATS: 24h VARIATION IN PLASMA CATECHOLAMINES, ANGIOTENSIN PEPTIDES, AND TELEMETRIC HEART RATE VARIABILITY
678
Cardiovascular remodeling after AVF surgery in rats assessed by a clinical MRI scanner
679
Cardiovascular remodeling and arterial hypertension in rheumatoid arthritis: Predisposing conditions and risk factors  
680
Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study
681
Cardiovascular remodeling, apoptosis, and drugs
682
Cardiovascular research in Spain. A comparative scientometric study
683
Cardiovascular response to sexual activity
684
Cardiovascular responses across stressor phases: The match of gender and gender-role identification with the gender relevance of the stressor
685
Cardiovascular Responses during Head-Down Crooked Kneeling Position Assumed in Muslim Prayers
686
Cardiovascular responses evoked by mild cool stimuli in primary Raynauds disease: the role of endothelin
687
Cardiovascular responses in humans to experimental chewing of gums of different consistencies
688
Cardiovascular responses in patients with acute allergic reactions treated with parenteral epinephrine
689
Cardiovascular responses induced by Catalase Inhibitior into the Fourth Cerebral Ventricle is changed in Wistar rats exposed to sidestream cigarette smoke
690
Cardiovascular responses of perimenopausal women to hormonal replacement therapy, ,
691
Cardiovascular responses of physically active colligate subjects during normal and warm conditions, and determination of sweat rates
692
Cardiovascular responses produced by resistin injected into paraventricular nucleus mediated by the glutamatergic and CRFergic transmissions within rostral ventrolateral medulla
693
Cardiovascular responses to agency and communion stressors in young women
694
Cardiovascular responses to aquatic walking in middle-aged and elderly persons with physical disabilities
695
Cardiovascular responses to chemoreflex activation with potassium cyanide or hypoxic hypoxia in awake rats
696
Cardiovascular responses to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being?
697
Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline
698
Cardiovascular responses to electrical stimulation of sympathetic nerves in the pithed mouse
699
Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction
700
Cardiovascular responses to laughter: A pilot project
701
Cardiovascular responses to microinjection of AMPA into the rostral commissural nucleus tractus solitarius of awake rats
702
CARDIOVASCULAR RESPONSES TO OROTRACHEAL INTUBATION IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING SURGERY (Comparing Fiberoptic Bronchoscopy With Direct Laryngoscopy)
703
CARDIOVASCULAR RESPONSES TO SCALP INFILTRATION, USING ADRENALINE, WITH OR WITHOUT LIGNOCAINE, DURING CRANIOTOMY
704
Cardiovascular responses to sciatic nerve stimulation are blocked by paratrigeminal nucleus lesion
705
Cardiovascular responses to the injection of L-glutamate in the lateral hypothalamus of unanesthetized or anesthetized rats
706
Cardiovascular Responses to Tonic Pain in REM Sleep-Deprived Rats Role of Melatonin and Beta Endorphin
707
Cardiovascular Risk After Bariatric Surgery for Obesity
708
Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction Original Research Article
709
Cardiovascular Risk Among Men Seeking Help for Erectile Dysfunction
710
Cardiovascular risk and atherosclerosis prevention
711
Cardiovascular risk and blood pressure reduction: an overview of the outcome trials
712
Cardiovascular risk and sildenafil
713
Cardiovascular risk assessment
714
Cardiovascular risk assessment
715
Cardiovascular risk assessment in HIV-infected patients attending a designated lipid clinic
716
Cardiovascular Risk Assessment of Liver Transplantation Candidates
717
Cardiovascular Risk Assessment of Pulmonary Embolism With the GRACE Risk Score
718
Cardiovascular Risk Assessment of the Liver Transplant Candidate
719
Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials
720
Cardiovascular risk changes after lipid lowering medications: are they predictable?
721
Cardiovascular risk continuum: implications of insulin resistance and diabetes
722
Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies
723
Cardiovascular Risk Factor Control and Adherence to Recommended Lifestyle and Medical Therapies in Persons With Coronary Heart Disease (from the National Health and Nutrition Examination Survey 2007–2010)
724
Cardiovascular risk factor profiles and their social gradient from adolescence to age 74 in a Swiss region
725
Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial
726
Cardiovascular Risk Factors among Children after a 2image-Year Intervention—The CATCH Study
727
Cardiovascular risk factors among retired attendees visiting primary care clinics
728
Cardiovascular Risk Factors and Acculturation in Yaquis and Tepehuanos Indians from Mexico
729
Cardiovascular risk factors and alcohol consumption in France and Northern Ireland Original Research Article
730
Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults
731
Cardiovascular Risk Factors and Confounders Among Nondrinking and Moderate-Drinking U.S. Adults
732
Cardiovascular Risk Factors and Coronary Atherosclerosis in Retired National Football League Players
733
Cardiovascular Risk Factors and COVID-19 incidence- Result from a population based study
734
Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program
735
CARDIOVASCULAR RISK FACTORS an‎d IN-HOSPITAL MORTALITY IN 1258 CASES OF CORONARY ARTERY BYPASS SURGERY IN TEHRAN HEART CENTER
736
Cardiovascular risk factors and migraine without aura: A case-control study.
737
Cardiovascular Risk Factors and Nutritional Intake are not Associated with Ultrasound-defi ned Increased Carotid Intima Media Thickness in Individuals Without a History of Cardiovascular Events
738
Cardiovascular Risk Factors and Specific Coronary Artery Calcification in Postmenopausal Women
739
Cardiovascular Risk Factors Are on the Rise in Developing Countries
740
Cardiovascular risk factors are really linked in the metabolic syndrome: This phenomenon suggests clustering rather than coincidence
741
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population
742
Cardiovascular risk factors associated with enlarged diameter of the abdominal aortic and iliac arteries in healthy women
743
Cardiovascular risk factors associated with migraine
744
Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study
745
Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study
746
Cardiovascular Risk Factors Determine Erectile and Arterial Function Response to Sildenafil
747
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction
748
Cardiovascular Risk Factors in Adolescence: Prevalence and Familial Aggregation
749
Cardiovascular risk factors in ethnic minority women aged ≤30 years
750
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients
751
Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid Profile
752
Cardiovascular Risk Factors in Italy
753
Cardiovascular risk factors in Kuwaiti adults with type 2 diabetes
754
Cardiovascular risk factors in Montana American Indians with and without diabetes Original Research Article
755
Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore Original Research Article
756
Cardiovascular risk factors in patients aged 85 or older with ischemic stroke
757
Cardiovascular risk factors in people abovetwenty years old in Gonabad, Iran
758
Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore Original Research Article
759
Cardiovascular risk factors in Tanzania: a revisit
760
Cardiovascular risk factors in the urban Mexican population: The FRIMEX study
761
Cardiovascular Risk Factors in Young Patients of Coronary Artery Disease: Differences over a Decade
762
Cardiovascular risk factors in youth with implications for aging: The Bogalusa Heart Study
763
Cardiovascular risk factors of hypertension, smoking and obesity: Emerging concerns among Pathan and Persian young adults?
764
Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension
765
Cardiovascular Risk Factors: A Study on the Prevalence of MS among 11-18 Years Old School Children in East of Iran, 2012
766
Cardiovascular risk in a hypertension clinic-implications of the Sheffield Table for lipid-lowering strategy
767
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis
768
Cardiovascular risk in long-term survivors of testicular cancer: Vaughn DJ, Palmer SC, Carver JR, Jacobs LA, Mohler ER, Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA; Department of Psychiatry, Universit
769
Cardiovascular Risk in Men Aged Over 40 in Boa Vista, Brazil
770
Cardiovascular risk in patients with bipolar disorder
771
Cardiovascular Risk in Patients With Fasting Blood Glucose Levels Within Normal Range
772
Cardiovascular Risk in Patients With Human Immunodeficiency Virus Infection: Incomplete Data
773
Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells
774
Cardiovascular risk in rheumatoid arthritis
775
Cardiovascular Risk in Survivors of Stroke Original Research Article
776
Cardiovascular Risk in Women With Non-Specific Chest Pain (from the Womenʹs Health Initiative Hormone Trials)
777
Cardiovascular Risk in Women With PCOS
778
Cardiovascular risk management in clinical practice: the midwest heart specialists experience
779
Cardiovascular risk models; is there an ideal model?
780
Cardiovascular risk of antidepressant use in elderly medicare beneficiaries: Comparison by therapeutic class
781
Cardiovascular Risk Perception among Iranian Women with type 2 Diabetes Mellitus
782
Cardiovascular Risk Profile and Lifestyle Habits in a Cohort of Italian Cardiologists (from the SOCRATES Survey)
783
Cardiovascular Risk Profile of Apparently Healthy Workers in a Tertiary Hospital in Nigeria
784
Cardiovascular risk profiles in UK-born Caribbeans and Irish living in England and Wales
785
Cardiovascular Risk Profiles of Oral Contraceptive Users and Nonusers: A Population-Based Study
786
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The life study Original Research Article
787
Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation
788
Cardiovascular risk score in Rheumatoid Arthritis
789
Cardiovascular risk stratification by means of the SCORE system in health care workers in Veracruz, Mexico
790
Cardiovascular risk stratification of pulmonary embolism
791
Cardiovascular Risk Stratification With Plasma B-Type Natriuretic Peptide Levels in a Community-Based Hypertensive Cohort
792
Cardiovascular Risk-Factors in the Eastern Iranian Population: Are We Approaching 25×25 Target?
793
Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study
794
CARDIOVASCULAR RISKS AMONG SHIFT AND NON-SHIFT WORKERS IN A PUBLIC MEDICAL CENTRE IN KUALA LUMPUR
795
Cardiovascular safety of cyclo-oxygenase-2 inhibitors
796
Cardiovascular safety of cyclo-oxygenase-2 inhibitors – Authorsʹ reply
797
Cardiovascular safety of fexofenadine HCI
798
Cardiovascular Safety of Fexofenadine HCl
799
Cardiovascular safety of maximal strength testing in healthy adults
800
Cardiovascular safety of rosiglitazone
801
Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates
802
Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing
803
Cardiovascular Screening and Emergency Procedures at Health Clubs and Fitness Centers
804
Cardiovascular sequelae of childhood hypertension
805
Cardiovascular solid mechanics. Cells, tissues, and organs: Jay D. Humphrey (Ed.); Springer verlag, New York, 2002, pp. 776, price US$99.00 hardback, ISBN 0-387-95168-7
806
Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): a cohort study
807
Cardiovascular stent design and vessel stresses: a finite element analysis
808
Cardiovascular stents: overview, evolution, and next generation
809
Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women, , , ,
810
Cardiovascular surgeonʹs remarks cause uproar in Spain
811
Cardiovascular system and intermittent stress: Bloodless adaptation to blood loss
812
Cardiovascular system is at higher risk of affecting by COVID-19
813
Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes
814
Cardiovascular Therapies and Risk for Development of Diabetes Review Article
815
Cardiovascular therapy of neurosurgical patients
816
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
817
Cardiovascular tissue engineering
818
Cardiovascular Tissue Engineering Therapy: So Near, So Far?
819
Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy
820
Cardiovascular Ultrasonographic Features and Clinical Findings for Intravenous Leiomyomatosis: A Case Report
821
Cardiovascular variability characteristics in obstructive sleep apnea
822
Cardiovascular variability during periodic leg movements: a spectral analysis approach
823
Cardiovascular, Antinociceptive and Sedative Effects of Medetomidine Infusion in Sevoflurane Anesthesia in Puppies
824
Cardiovascular, Haematological and Biochemical Responses After Large Volume Blood Collection in Horses
825
Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls
826
Cardiovascular, respiratory, and panic reactions to epinephrine in panic disorder patients
827
Cardiovascular-radical outcome method is effective in complex congenital cardiac lesions
828
Cardiovascular-Renal Responses to Long-Term Nitric Oxide Inhibition During Angiotensin II-AT1 Receptor Inhibition
829
Cardioversion for Atrial Fibrillation: Does Inflammation Matter?
830
Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion
831
Cardioversion of atrial fibrillation in the elderly
832
Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure
833
Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?
834
Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department, ,
835
Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin
836
Cardioversion With Novel Oral Anticoagulants: Reconfirming a 50-Year-Old Standard
837
Cardioverter defibrillator implantation in an adult with isolated noncompaction of the ventricular myocardium
838
Cardioverter-defibrillator implantation in the catheterization laboratory: Initial experiences in 48 patients
839
Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms
840
CardioVision 2020: Program Acceptance and Progress After 4 Years Original Research Article
841
Cardiovocal syndrome after transradial cardiac catheterization: An unusual complication
842
CardioWest Total Artificial Heart in a Moribund Adolescent With Left Ventricular Thrombi
843
CardioWest Total Artificial Heart: Bad Oeynhausen Experience
844
Cardiprotective effects of chronic hypoxia and preconditioning are not additive. Role of mitochondrial KATP channels
845
Cardo poly(arylene ether sulfone) block copolymers with pendant imidazolium side chains as novel anion exchange membranes for direct methanol alkaline fuel cell
846
Cardosin A as a model aspartic proteinase for the study of organic solvent effects: An overview on catalytic and structural aspects
847
Cardre to be absorbed into LCW after acquisition by Sensient Technologies
848
Cardré’s black iron oxide for eye make-up
849
Cardy states, factorization and idempotency in closed string field theory Original Research Article
850
Cardy–Verlinde formula and asymptotically de Sitter spaces
851
Cardy–Verlinde formula and thermodynamics of black holes in de Sitter spaces Original Research Article
852
Care after cure in leprosy
853
Care and cure. An integrated approach to psychosomatic medicine: A report from the second annual conference the EAPM, Sibiu, 2014
854
Care and despair in the UK National Health Service
855
Care and Do Not Harm: Possible Misunderstandings With Quaternary Prevention (P4); Comment on “Quaternary Prevention, an Answer of Family Doctors to Over Medicalization”
856
Care and feeding of reproducible econometrics
857
Care and NonCare‑Related Activities among Critical Care Nurses: A Cross‑Sectional Observational Time and Motion Study
858
Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations
859
Care and Support for Adolescents Living with HIV/AIDS in School Settings: Perspectives of Teachers and Administrators in the Southern Highlands of Tanzania
860
Care and Use of Diamond Knives
861
Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort study
862
Care Burden in Parents of Children with Leukemia: A Cross-Sectional Study in the West of Iran
863
Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non–ST-Elevation myocardial infarction
864
Care delivery innovation in an integrated health system
865
Care Dependency and Diabetes Self-Care Activities in Elderly Individuals with Diabetes
866
Care disparities: Moving from gray to black and white
867
Care emerges from chaos
868
Care for elderly in USA goes subacute
869
Care for Evidence-Based Applications During Pregnancy
870
Care for stroke patients
871
Care for stroke patients
872
Care for stroke patients
873
Care in comatose surviors of cardiac arrest
874
Care in the community
875
Care Instability in Nursing Homes; A Qualitative Study
876
Care Integration – From “One Size Fits All” to Person Centred Care; Comment on “Achieving Integrated Care for Older People: Shuffling the Deckchairs or Making the System Watertight for the Future?”
877
Care Management Challenges for Diabetic Foot Ulcers: A Qualitative Study
878
Care meanings, expressions, and experiences of those with chronic mental illness
879
Care needs and point prevalence of post-acute patients in the acute medical wards of an Italian hospital
880
Care needs and preferences from the perspective of COVID-19 patients: A qualitative study
881
Care Needs in the Phase I of Cardiac Rehabilitation: A Hybrid Concept Analysis
882
Care Needs of Children with Inborn Errors of Metabolism and Their Parents: An Integrative Review
883
Care Needs of Patients with Cancer; a Systematic Review
884
Care of acute myocardial infarction by nonivasive and invasive cardiologist: Procedure use, cost and outcome
885
Care of burns victims in Europe
886
Care of cardiac surgical patients
887
Care of children who have had surgery for congenital heart disease
888
CARE OF DEMENTIA IN CANADA: A COLLABORATIVE CARE APPROACH WITH A CENTRAL ROLE FOR THE PRIMARY CARE PHYSICIAN
889
Care of Diabetic Retinopathy Patients in Oman
890
Care of handicapped in Gaza
891
Care of learning-disabled Russian children condemned
892
Care of Minor Injuries by Emergence Nurse Practitioners or Junior Doctors: A Randomised Controlled Trial
893
Care of minor injuries by emergency nurse practitioners or junior doctors: a randomised controlled trial Original Research Article
894
Care of non-ST-segment elevation patients: Insights from the crusade national quality improvement initiative
895
Care of older people in nursing homes: an Intensive Programme as an educational activity within Erasmus–Socrates
896
Care of terminally-ill patients: an opinion survey among critical care healthcare providers in the Middle East
897
Care of the adult with congenital heart disease: introduction
898
Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review
899
Care of the critically ill parturient: oliguria and renal failure
900
Care of the elderly with gastrointestinal problems in family practice
901
Care of the end-stage renal disease patient on dialysis in the ED
902
Care of the organization: Training and development strategies
903
Care of the pacemaker/implantable cardioverter defibrillator patient in the ED
904
Care of the patient close to death
905
Care of the renal transplant recipient in the emergency department
906
Care of the woman with hypertension in pregnancy: the viewpoint of the midwife
907
Care or control: health or criminal justice options for the long-term seriously mentally ill in a Canadian province
908
Care or scare: The safety of youth in congregate care in New York City
909
Care pathways for south Asian and white people with depressive and anxiety disorders in the community
910
Care pathways in thrombosis management: the INNOVATE peer-to-peer educational initiative
911
Care process and satisfaction analysis of a transmural home care program Original Research Article
912
Care Process in Iranian Nursing Homes: A Grounded Theory Study
913
Care Providers’ Perspectives on Quality Prenatal Care in High-risk Pregnancies: A Qualitative Study
914
Care provision and community adjustment of rural consumers with serious mental illness
915
Care seeking in Sri Lanka: one possible explanation for low childhood mortality
916
Care Seeking Patterns of STIs-Associated Symptoms in Iran: Findings of a Population-Based Survey
917
Care Seeking Practices of Mothers Regarding Four Key Family Practices Related to Child Health and Development
918
Care to be a nurse? Reflections on a radio broadcast and its ramifications for nursing today
919
Care Work Migration in Germany: Semi-Compliance and Complicity
920
CARE: an automobile crash data analysis tool
921
Carebene and isocyanide ligation at ruthenium(II) with (η6-arene) and tethered phosphinopropylarene ligands
922
CAREdose 4D Application in Brain CT Scan: The Effect on Dose and Image Quality
923
Career advancement and scientific performance in universities
924
Career analysis: a case study of hotel general managers in Australia
925
Career anchors and disturbances in job turnover decisions – A case study of IT professionals in Taiwan
926
Career anchors and paths: The case of Gay, Lesbian, & Bisexual workers
927
Career Aspirations And Pregnancy Intentions In Pregnant Teens
928
Career atifaction and urgical practice pattern among female ophthalmologit
929
Career choices for career growth
930
Career choices in health care: Is nursing a special case? A content analysis of survey data
931
Career concerns and mandated disclosure
932
Career concerns in a simple experimental labour market
933
CAREER CONSULTATION AS AN INTERVENTION STRATEGY IN ALLEVIATING FAMILY’S MENTAL HEALTH: A CASE STUDY ON STUDENTS WITH DISABILITIES
934
Career Counseling For Management Students
935
CAREER COUNSELLING FOR CLIENTS WITH PHYSICAL DISABILITIES IN MALAYSIAN CONTEXT
936
Career Decision-Making Self-Efficacy and Its Implications in High School Students during the Covid-19 Pandemic
937
Career decisions: The interim option
938
Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University – Uganda Virus Research Institute research and training programme
939
Career development in organizations and beyond: Balancing traditional and contemporary viewpoints
940
Career development of female managers in retailing: Inhibitors and enablers
941
Career Development of Nursing Preceptors in Iran: A Descriptive Study
942
Career Development of School Psychologists
943
Career Development through E-Learning: The Importance of a Competence-Based Learning Approach
944
Career Dis-integration and Re-integration in Mergers and Acquisitions:: Managing Competence and Motivational Intangibles
945
Career Education in the Primary Grades: Building Work-Readiness Through an Experiential Curriculum
946
Career Guidance Methods for Increasing Career Maturity in Grade IX Students at SMPN 15 Yogyakarta
947
Career guidancefor student nurses: an unmet need
948
Career Indecision and Career Anxiety in High School Students: An Investigation through Structural Equation Modelling
949
CAREER MANAGEMENT COMPETENCY AMONG VOCATIONAL SKILLED MILITARY RETIREES
950
Career management of business expatriates from China
951
Career mothers and perfectionism: stress at work and at home
952
CAREER MOVES: TRANSFER AND RANK CHALLENGE DECISIONS BY MALE LONG-TAILED MACAQUES
953
Career Obstacles of Working Women: A Research in Eskişehir
954
Career options in aerospace and aviation medicine
955
Career orientations and career success among research, and development and engineering professionals
956
Career orientations of information systems employees in South Africa
957
Career paths beyond nursing and the contribution of nursing experience and skills in attaining these positions
958
Career paths for the 21st century. How to beat job insecurity: Jim Duncan and David Oates, Century Business (1996), £12.99
959
Career Paths to Public Health: Programs at the Centers for Disease Control and Prevention Review Article
960
Career Perception at the Republic Indonesian Police Organization Impact of Distributive Fairness, Procedural Fairness and Career Satisfaction on Affective Commitment
961
Career planning and job searching in the information age : edited by Elizabeth A. Lorenzen. Binghampton, NY: Haworth Press, 1996 (simultaneously published as The Reference Librarian, no. 55). 120p. $29.95. ISBN 1-56024-838-6
962
CAREER PLANNING BY THE DOCTORS IN NWFP
963
Career plans and work perceptions of preservice teachers
964
Career plateauing and work attitudes: Moderating effects of mentoring others with Nigerian employees
965
Career preferences and the work–family balance in medicine: gender differences among medical specialists
966
Career profile of dentists in Saudi Arabia
967
Career progress of recent tourism graduates
968
Career prospects for female university researchers have not improved
969
Career Research Productivity Patterns of Marketing Academicians
970
Career Selection: Role of Parent’s Profession, Mass Media and Personal Choice
971
Career Self-Efficacy Among African-American Female Adolescents
972
Career skills gained from an international equine experience
973
Career stress responses among hospitality employees
974
Career Women as a Role Model in the Formation of Morals
975
Career, experience and returns to human capital: is the dual labour market hypothesis relevant for the UK?
976
Careers and clusters: analyzing the career network dynamic of biotechnology clusters
977
Careers and human resource management—a European perspective
978
Careers and lives socialization, structural lag, and gendered ambivalence
979
Careers and mortality in France: evidence on how far occupational mobility predicts differentiated risks
980
Careers in Medicine or what do you want when you grow up?
981
Careers in science: policy issues according to Nature and Science editorials
982
Careers in the next millennium: directions for future research
983
Careers within careers: Reconceptualizing the nature of career anchors and their consequence
984
Careful considerations when reporting and evaluating the grey water footprint of products
985
Careful Co-Planning for Effective Team Teaching in Mathematics
986
Careful naming of disorders
987
Careful partial harvesting in conservation stands and retention of large oaks favour oak regeneration Original Research Article
988
Care-full markets? A reply to John Christman and Veronica Crossa
989
Caregiver and peer responses to children with language and motor disabilities in inclusive preschool programs
990
Caregiver attributions are not just for children: Evidence for generalized low power schemas
991
Caregiver burden among Iranian heart failure family caregivers: A descriptive, exploratory, qualitative study
992
Caregiver burden among Japanese informal caregivers of cognitively impaired elderly in community settings
993
Caregiver Burden among Parents of Hearing Impaired and Intel- lectually Disabled Children in Pakistan
994
Caregiver burden and coping
995
Caregiver burden and disability in somatization disorder
996
Caregiver burden and health promotion
997
Caregiver Burden and Its Associated Factors in Caregivers of Children and Adolescents with Chronic Conditions
998
Caregiver Burden and its Determinants among the Family Members of Patients with Dementia in Iran
999
Caregiver burden and outcomes of caregiving of spouses of patients who undergo coronary artery bypass graft surgery
1000
Caregiver Burden and Quality of Life among Caregivers of Cancer Patients in Ahvaz, 2021 - 2022: A Cross-Sectional Study
بازگشت